CORNEAT VISION, LTD.

3 FDA enforcement actions

3 Total Recalls

0 Class I

3 Class II

0 Class III

Firm Details

Product Types: device
States: N/A

All Recalls

Class II: Risk 08/18/2025 device

Reviewed complaints have identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.
Class II: Risk 08/18/2025 device

Reviewed complaints have identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.
Class II: Risk 10/16/2024 device

Retroactive; Due to complaints, labeling correction for permanent tissue-integrating surgical matrices to include prevention and management of would dehiscence.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.